Olr185 inhibitors represent a distinct class of chemical compounds that specifically target and modulate the activity of the Olr185 receptor, a member of the olfactory receptor (OR) family. Olfactory receptors, primarily known for their role in the detection of odorants, are G-protein-coupled receptors (GPCRs) expressed in the sensory neurons of the olfactory epithelium. However, research has expanded their presence beyond the olfactory system, suggesting a broader physiological significance. The Olr185 receptor, like other olfactory receptors, is characterized by a seven-transmembrane domain structure, which allows it to interact with specific ligands. Inhibitors of Olr185 function by binding to the receptor and preventing the activation or downstream signaling cascades typically triggered by ligand binding. This inhibition can modulate the receptor's conformational state, interfere with the coupling to G-proteins, or block the receptor's ability to initiate signal transduction pathways. Such detailed mechanistic studies are crucial for understanding the intricate dynamics of Olr185 receptor function.
The development of Olr185 inhibitors has provided a unique tool for studying the role of this receptor in various biological processes. By selectively inhibiting Olr185, researchers can dissect the specific pathways and physiological responses mediated by this receptor, thereby shedding light on its broader biological significance. The design and synthesis of these inhibitors often involve intricate chemical modifications aimed at increasing specificity and potency. These modifications may include alterations to functional groups, stereochemistry, or molecular scaffolds to enhance the inhibitor's binding affinity for the Olr185 receptor. Additionally, advanced techniques in structural biology and computational modeling are frequently employed to predict the interaction between Olr185 and its inhibitors, guiding the rational design of more effective compounds. As a result, Olr185 inhibitors serve as a critical resource in the exploration of olfactory receptor function and the complex signaling networks in which they participate.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor; potentially alters pathways that could indirectly impact Olr185. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
mTOR inhibitor; may modulate signaling pathways indirectly affecting Olr185 activity. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Inhibits BCR-ABL, c-KIT; could influence pathways that intersect with Olr185's signaling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Multi-kinase inhibitor; may indirectly impact signaling pathways related to Olr185. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $87.00 $135.00 $293.00 $505.00 $3827.00 | 42 | |
EGFR inhibitor; might modify pathways indirectly related to Olr185. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Inhibits EGFR, HER2; could indirectly alter Olr185-related signaling pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
SRC-family, BCR-ABL inhibitor; potentially affects pathways that intersect with Olr185. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
BCR-ABL inhibitor; may indirectly influence pathways related to Olr185's activity. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
Multi-targeted receptor tyrosine kinase inhibitor; could impact signaling pathways related to Olr185. | ||||||
Sunitinib Malate | 341031-54-7 | sc-220177 sc-220177A sc-220177B | 10 mg 100 mg 3 g | $197.00 $520.00 $1093.00 | 4 | |
Inhibits multiple receptor tyrosine kinases; potentially modifies pathways impacting Olr185. | ||||||